Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201105396 Principal Investigator: Picus, Joel
Title: A Randomized Phase II Study of Afinitor (RAD001) vs. Sutent (Sunitinib) in Patients with Metastatic Non-Clear Renal Cell Carcinoma (ASPEN)
Phase: II Disease Site: Kidney
Participating Site(s):
 
Main Campus
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to learn what the effects are of Afinitor or Sutent on patients and kidney cancer. These effects may include the ability of these study drugs to shrink kidney cancer, to keep kidney cancer from growing, to keep kidney cancer from spreading, and to keep kidney cancer from worsening patient health.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)